LongCovid
In a study recently published study, researchers from the University of New South Wales and St. Vincent’s Hospital have identified a key pathway, involved in inflammation, which appears…
Do not miss this interesting article published by Fortune based on a paper published recently in Nature Medicine. The article also includes an interview with the senior author of that paper,…
In this prospective observational cohort study carried out by Charité – Universitätsmedizin Berlin, symptom severity and various biomarkers were evaluated in 106 patients with Post-COVID-19 syndrome (PCS) with moderate to…
Two very interesting papers have just been published on the 2-year follow up of over 100,000 people with Covid and millions of uninfected controls: In a new edition…
“Because COVID-19 is still around, reports of people getting reinfected with COVID-19 a second, third or even fourth time are becoming more common. The safest bet in reducing…
Very interesting and relevant interview (text and audio) with Prof. Danny Altmann about Long COVID and his recently published Nature review on the immunology of Long Covid. “My…
World’s largest study of long COVID will evaluate potential therapies for brain fog, sleep disruption and more. The US National Institutes of Health (NIH) announced yesterday that it…
The 2nd official peer-reviewed article generated by the Long COVID project has just been published by Viruses MDPI: The Stereotypic Response of the Pulmonary Vasculature to Respiratory Viral Infections: Findings…
Very interesting opinion article on Long COVID published by Los Angeles Times. “In a world where most pandemic safety protocols have evaporated, where is the sense of urgency to treat, or…
This new review article published by the Molecular Psychiatry journal presents an overview of Published epidemiology, symptoms, and risk factors of Long COVID. This review also summarises potential pathophysiological mechanisms and biomarkers for precise prevention,…